Skip to main content

Vertex Pharmaceuticals to acquire Alpine Immune Sciences for $4.9B

By The Wall Street Journal  
   April 11, 2024

The deal would give Vertex access to potential kidney-disease treatment.

Full story


Get the latest on healthcare leadership in your inbox.